Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

22.21
-0.5200-2.29%
Post-market: 22.210.00000.00%19:30 EDT
Volume:2.34M
Turnover:51.78M
Market Cap:2.30B
PE:-6.51
High:22.60
Open:22.49
Low:21.55
Close:22.73
52wk High:28.23
52wk Low:9.00
Shares:103.41M
Float Shares:74.11M
Volume Ratio:1.97
T/O Rate:3.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4102
EPS(LYR):-3.0514
ROE:-80.30%
ROA:-40.06%
PB:5.70
PE(LYR):-7.28

Loading ...

Oct 11, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Major Issues Report

Form 8-K - Current report
Apr 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2024

Major Issues Report

Form 8-K - Current report